172 related articles for article (PubMed ID: 1457622)
1. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F
Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622
[TBL] [Abstract][Full Text] [Related]
2. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
[TBL] [Abstract][Full Text] [Related]
4. EEG brain mapping in diagnostic and therapeutic assessment of dementia.
Saletu B; Anderer P; Paulus E; Grünberger J; Wicke L; Neuhold A; Fischhof PK; Litschauer G
Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S57-75. PubMed ID: 1781975
[TBL] [Abstract][Full Text] [Related]
5. Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer type and multiinfarct dementia.
Martin-Loeches M; Gil P; Jimenez F; Exposito FJ; Miguel F; Cacabelos R; Rubia FJ
Biol Psychiatry; 1991 Feb; 29(3):211-23. PubMed ID: 2015328
[TBL] [Abstract][Full Text] [Related]
6. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
[TBL] [Abstract][Full Text] [Related]
7. Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
Saletu B; Möller HJ; Grünberger J; Deutsch H; Rössner M
Neuropsychobiology; 1990-1991; 24(4):173-84. PubMed ID: 2135708
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of xantinolnicotinate in patients with dementia.
Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
[TBL] [Abstract][Full Text] [Related]
9. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and assessment of dementia using functional brain imaging.
Leuchter AF; Walter DO
Int Psychogeriatr; 1989; 1(1):63-72. PubMed ID: 2490905
[TBL] [Abstract][Full Text] [Related]
11. Electroencephalography and single photon emission computed tomography in dementia: a comparative study.
Sloan EP; Fenton GW; Kennedy NS; MacLennan JM
Psychol Med; 1995 May; 25(3):631-8. PubMed ID: 7480442
[TBL] [Abstract][Full Text] [Related]
12. EEG power spectra and cognitive change in geriatric psychiatry: a longitudinal study.
Sloan EP; Fenton GW
Electroencephalogr Clin Neurophysiol; 1993 Jun; 86(6):361-7. PubMed ID: 7686470
[TBL] [Abstract][Full Text] [Related]
13. [EEG studies in Alzheimer dementia and multi-infarct dementia at various times of the day].
Wendland KL; Zarnitz T; Gundel A
Z Gerontol; 1991; 24(1):33-8. PubMed ID: 2038888
[TBL] [Abstract][Full Text] [Related]
14. Quantitative EEG in patients with presenile and senile dementia of the Alzheimer type.
Miyauchi T; Hagimoto H; Ishii M; Endo S; Tanaka K; Kajiwara S; Endo K; Kajiwara A; Kosaka K
Acta Neurol Scand; 1994 Jan; 89(1):56-64. PubMed ID: 8178630
[TBL] [Abstract][Full Text] [Related]
15. Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia.
Dierks T; Perisic I; Frölich L; Ihl R; Maurer K
Psychiatry Res; 1991 Nov; 40(3):181-94. PubMed ID: 1780391
[TBL] [Abstract][Full Text] [Related]
16. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.
Herrmann WM; Stephan K
Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
[TBL] [Abstract][Full Text] [Related]
18. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
[TBL] [Abstract][Full Text] [Related]
19. The GBS scale in multi-infarct dementia and senile dementia of Alzheimer type.
Olafsson K; Kørner A; Bille A; Jensen HV; Thiesen S; Andersen J
Acta Psychiatr Scand; 1989 Jan; 79(1):94-7. PubMed ID: 2929386
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of vincamine in dementia.
Fischhof PK; Möslinger-Gehmayr R; Herrmann WM; Friedmann A; Russmann DL
Neuropsychobiology; 1996; 34(1):29-35. PubMed ID: 8884757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
